HLN · Consumer Staples
Haleon Plc
25/100
Smart-money confidence1 of 3 sources positive
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
33
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$42.7B
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Exchange
NYSE
About HALEON PLC
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products…
Who's behind the signal
Every informed buyer we can see on HLN, across all three feeds.
Hedge funds · 6
Bridgewater Associates (Dalio)
New position
Point72 (Steve Cohen)
Increased +39%
D.E. Shaw & Co
Increased +1108%
Citadel Advisors
Increased +66%
AQR Capital Management
Increased +73%
Tweedy Browne
Unchanged
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 9 on record
Disclosures from 2023-01-13 to 2024-06-21
The newest disclosure we hold for this stock is 2024-06-21.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2024-06-21 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2024-05-20 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2023-07-21 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2023-07-20 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2023-07-19 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2023-07-10 | Daniel S. Goldman · D-NY | House | Sold | $15,001 - $50,000 |
| 2023-03-31 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2023-02-27 | Daniel S. Goldman · D-NY | House | Bought | $1,001 - $15,000 |
| 2023-01-13 | Daniel S. Goldman · D-NY | House | Bought | $1,001 - $15,000 |
Not a model pick — but on our radar.
HALEON PLC isn't in the top-10 model right now, but 6 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
6
Investors
1
New positions
4
Increasing
0
Decreasing
1
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.3×
% of portfolio
0.0%
Position change
NEW
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+39%
0.1% of Point72's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+1108%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+66%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+73%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.2×
% of portfolio
0.1%
Position change
—
0.1% of Tweedy Browne's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to HALEON PLC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell HALEON PLC or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime